Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.78 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.69 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.69 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.69 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.69 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.68 |
| ▸ | TAS2R31 | P59538 | 1/20 | 0.68 |
| ▸ | CREB1 | P16220 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8064417 | 0.97 | HDAC6 (0.77) | HDAC6CYP1A1CYP1A2OPRD1CYP1B1 | |
| SCHEMBL8064420 | 0.95 | HDAC6 (0.80) | HDAC6CYP1A1CYP1A2OPRD1CYP1B1 | |
| SCHEMBL8052592 | 0.93 | HDAC6 (0.70) | HDAC6 | |
| SCHEMBL8064232 | 0.90 | HDAC6 (0.83) | HDAC6CYP1A1CYP1A2OPRD1CYP1B1 | |
| SCHEMBL8062177 | 0.90 | — | — | |
| Eupatilin SCHEMBL1033509 | 0.88 | HDAC6 (1.00) | HDAC6CYP1A1CYP1A2OPRD1CYP1B1 | |
| Eupatilin SCHEMBL29926197 | 0.88 | HDAC6 (1.00) | HDAC6CYP1A1CYP1A2OPRD1CYP1B1 | |
| Eupatilin SCHEMBL29568655 | 0.88 | HDAC6 (1.00) | HDAC6CYP1A1CYP1A2OPRD1CYP1B1 | |
| SCHEMBL7605304 | 0.88 | CYP1A1 (0.64) | HDAC6CYP1A1CYP1A2OPRD1CYP1B1 | |
| SCHEMBL8052853 | 0.88 | HDAC6 (0.71) | HDAC6CYP1A1CYP1A2OPRD1CYP1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6025387-A | Gastroprotective flavone/flavanone compounds with therapeutic effect on inflammatory bowel disease | DONG A PHARMACEUTICAL CO., LTD. (KR) | 2000-02-15 | — | — | US | disclosed |